This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

DaVita HealthCare Partners Inc (DVA)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 11.76B 8.19B 6.98B 6.45B
Cost of Sales 8.20B 5.58B 4.68B 4.47B
Gross Operating Profit 3.57B 2.61B 2.30B 1.97B
Selling, General, and Administrative Expenses 1.18B 984.75M 888.81M 750.25M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 2.38B 1.62B 1.41B 1.22B
Depreciation & Amortization 528.12M 343.91M 267.32M 234.38M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -300.68M 9.15M 11.76M -61.96M
Special Income / Charges 0.00 0.00 -24.00M 0.00
Total Income Before Interest Expenses (EBIT) 1.55B 1.29B 1.13B 926.06M
Interest Expense 429.94M 288.55M 241.09M 181.61M
Pre-Tax Income 1.12B 1.00B 892.67M 744.46M
Income Taxes 381.01M 359.84M 315.74M 260.24M
Minority Interest 123.76M 105.22M 95.39M 78.54M
Net Income From Continuing Operations 743.96M 641.46M 576.93M 484.22M
Net Income From Discontinued Operations 13.24M -222.00K -3.54M 0.00
Net Income From Total Operations 757.20M 641.24M 573.40M 484.22M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 633.45M 536.02M 478.00M 405.68M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
743.96M 641.46M 600.93M 484.22M
Preferred Dividends
Net Income Available To Common 743.96M 641.46M 576.93M 484.22M
Basic EPS from Continuing Ops. 2.95 2.79 2.55 2.39
Basic EPS from Discontinued Ops. 0.06 0.00 -0.02 0.00
Basic EPS from Total Operations 3.01 2.79 2.53 2.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.01 0.00 0.00 -0.39
Basic EPS, Total 3.02 2.79 2.53 2.00
Basic Normalized Net Income/Share 2.95 2.79 2.65 2.39
EPS fr Continuing Ops. 2.89 2.74 2.50 2.35
EPS fr Discontinued Ops 0.06 0.00 -0.02 0.00
EPS fr Total Ops. 2.95 2.73 2.48 2.35
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 -0.38
EPS, Total 2.95 2.74 2.48 1.97
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.89 2.74 2.60 2.35
Dividends Paid per Share 0.00 0.00 0.00 0.00
DVA News

DVA DaVita HealthCare Partners Inc

Analysts Ratings for DVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 6 6 6
Moderate Buy 1 2 2 3
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET DVA ANALYST REPORT

Brokerage Partners

DVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs